Table 1.
Group with autonomic dysfunction | Group without autonomic dysfunction | |||
Group size | 14 | 22 | ||
Age (years)† | 76±6 | 65±9 | ||
Gender | 8 female / 6 male | 17 female / 5 male | ||
Dementia Diagnosis | 6 DAT / 8 bvFTD | 8 DAT/14 bvFTD | ||
Descriptive data Ewing battery | ||||
CV Mean±Std (Median) | 3.89±1.88 (3.53) [n = 14] | 3.73±1.46 (3.77) [n = 22] | ||
El Mean±Std (Median))† | 1.12±0.08(1.14) [n = 11] | 1.28±0.22 (1.22)[n = 21] | ||
VAL Mean±Std (Median))† | 1.12±0.14 (1.11) [n = 11] | 1.32±0.24 (1.30) [n = 20] | ||
Phase llb normal / blocked | 5/5 | 17/3 | ||
Phase IV normal /blocked | 5/6 | 17/3 | ||
TILT30/15 Mean±Std (Median)‡ | 1.1±0.13 (1.09) [n = 14] | 1.16±0.10 (1.15) [n = 22] | ||
Descriptive data LFnu | ||||
LFnu _ Resting (%) Mean±std (Median) | 71.18±23.17(78.22) | 72.8±16.07 (78.21) | ||
LFnu _ hut (%) Mean±Std (Median) | 76.84±21.22 (80.48) | 78.99±16.98 (84.75) | ||
non- parametric Wilcoxon ranksum test (equality of medians; H0: LFnu _ Resting = LF nu) | ||||
δ= LFnuhut - LFnu–Resting (%) | 2.26 | 6.53† | ||
p-Value | 0.395 | 0.036 |
†significantly different (p-value < 5%) Wilcoxon ranksum test. ‡significantly different (p-value < 14%) Wilcoxon ranksum test.